Similarly, in bladder cancer, LACTB modulates ferroptosis and mitochondrial function by inducing erastin-mediated ferroptosis, which exacerbates mitochondrial dysfunction and ROS production (Figure 3), counteracting the ferroptosis-inhibitory effects of PCBP1. This evidence concerns the gene PCBP1 and urinary bladder carcinoma.